Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 May;19(5):826–830. doi: 10.1128/aac.19.5.826

Chemoprophylaxis with cefoxitin and cephalothin in orthopedic surgery: a comparison.

M B Rosenfeld, J Campos, K R Ratzan, I Uredo
PMCID: PMC181530  PMID: 7027924

Abstract

Forty-eight patients who underwent elective hip or knee surgery were randomly divided into two groups. A total of 22 patients received a single 1-g preoperative bolus of cefoxitin, and 26 patients received a single 1-g preoperative dose of cephalothin. At various time intervals, serum and bone samples were taken during the operative procedure. Our data indicated that whereas serum levels of cefoxitin and cephalothin were maintained for at least 2h at levels capable of inhibiting most gram-positive cocci and many gram-negative rods, bone levels of cefoxitin rather rapid decay over a 2-h period. Moreover, in only 58% of the entire cephalothin-treated group were bone levels detectable and then only at a concentration that would inhibited gram-positive cocci. No significant morbidity was observed in either treatment group.

Full text

PDF
826

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyd R. J., Burke J. F., Colton T. A double-blind clinical trial of prophylactic antibiotics in hip fractures. J Bone Joint Surg Am. 1973 Sep;55(6):1251–1258. [PubMed] [Google Scholar]
  2. Burke J. F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery. 1961 Jul;50:161–168. [PubMed] [Google Scholar]
  3. Cunha B. A., Gossling H. R., Pasternak H. S., Nightingale C. H., Quintiliani R. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg Am. 1977 Oct;59(7):856–859. [PubMed] [Google Scholar]
  4. Ericson C., Lidgren L., Lindberg L. Cloxacillin in the prophylaxis of postoperative infections of the hip. J Bone Joint Surg Am. 1973 Jun;55(4):808-13, 843. [PubMed] [Google Scholar]
  5. Fogelberg E. V., Zitzmann E. K., Stinchfield F. E. Prophylactic penicillin in orthopaedic surgery. J Bone Joint Surg Am. 1970 Jan;52(1):95–98. [PubMed] [Google Scholar]
  6. Kanyuck D. O., Welles J. S., Emmerson J. L., Anderson R. C. The penetration of cephalosporin antibiotics into bone. Proc Soc Exp Biol Med. 1971 Mar;136(3):997–999. doi: 10.3181/00379727-136-35414. [DOI] [PubMed] [Google Scholar]
  7. Kolczun M. C., Nelson C. L., McHenry M. C., Gavan T. L., Pinovich P. Antibiotic concentrations in human bone. A preliminary report. J Bone Joint Surg Am. 1974 Mar;56(2):305–310. [PubMed] [Google Scholar]
  8. Kosmidis J., Hamilton-Miller J. M., Gilchrist J. N., Kerry D. W., Brumfitt W. Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin. Br Med J. 1973 Dec 15;4(5893):653–655. doi: 10.1136/bmj.4.5893.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mitchell C., Ehrlich M. G., Siffert R. S. Comparative bacteriology of early and late orthopedic infections. Clin Orthop Relat Res. 1973 Oct;(96):277–287. [PubMed] [Google Scholar]
  10. Patel D., Moellering R. C., Jr, Thrasher K., Fahmy N. R., Harris W. H. The effect of hypotensive anesthesia on cephalothin concentrations in bone and muscle of patients undergoing total hip replacement. J Bone Joint Surg Am. 1979 Jun;61(4):531–538. [PubMed] [Google Scholar]
  11. Pavel A., Smith R. L., Ballard A., Larsen I. J. Prophylactic antibiotics in clean orthopaedic surgery. J Bone Joint Surg Am. 1974 Jun;56(4):777–782. [PubMed] [Google Scholar]
  12. Pearson H. E., Harvey J. P., Jr Bacteroides infections in orthopedic conditions. Surg Gynecol Obstet. 1971 May;132(5):876–880. [PubMed] [Google Scholar]
  13. Ratzan K. R., Ruiz C., Irvin G. L., 3rd Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease. Antimicrob Agents Chemother. 1974 Oct;6(4):426–431. doi: 10.1128/aac.6.4.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sabath L. D., Garner C., Wilcox C., Finland M. Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrob Agents Chemother. 1976 Jun;9(6):962–969. doi: 10.1128/aac.9.6.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schrogie J. J., Rogers J. D., Yeh K. C., Davies R. O., Holmes G. I., Skeggs H., Martin C. M. Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporins. Rev Infect Dis. 1979 Jan-Feb;1(1):90–98. doi: 10.1093/clinids/1.1.90. [DOI] [PubMed] [Google Scholar]
  16. Verbist L. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli. Antimicrob Agents Chemother. 1976 Oct;10(4):657–663. doi: 10.1128/aac.10.4.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wick W. E. In vitro and in vivo laboratory comparison of cephalothin and desacetylcephalothin. Antimicrob Agents Chemother (Bethesda) 1965;5:870–875. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES